Antipsychotic discontinuation in schizophrenia: rational or reckless?
Robert B. Zipursky, Ofer Agid, Gary Remington · 2025
Read Antipsychotic discontinuation in schizophrenia: rational or reckless? by Robert B. Zipursky, Ofer Agid, Gary Remington (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12712088.txt.
Description
Robert B Zipursky, Ofer Agid, and Gary Remington answer a recent challenge to lifelong antipsychotic treatment in schizophrenia. Their 2025 commentary engages a paper by Moncrieff and Horowitz that set out how patients might stop these drugs. The authors first narrow the ground: the question is discontinuation in schizophrenia specifically, not psychosis in general, and stopping entirely, not lowering the dose.
They argue the case against long-term treatment rests on premises the weight of evidence does not support. Decades of research, they note, show schizophrenia is highly treatable, relapses are largely preventable, and maintenance treatment after early episodes has strong support. Other causes of a first psychosis, from brief disorders to substance-induced states and bipolar illness, follow different rules, so pooling them muddies the guidance. Dose reduction is taken up separately, after the main question of stopping is addressed on its own terms.
Catalog record
| CREATOR | Robert B. Zipursky, Ofer Agid, Gary Remington |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |